04-17511. Memorandum of Understanding Between the Food and Drug Administration and the University of California, Lawrence Livermore National Laboratory  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the University of California (UC), Lawrence Livermore National Laboratory to establish the framework for collaborative research and development and emergency triage response efforts. FDA and UC Lawrence Livermore National Laboratory will work collaboratively to expedite development of methods and technologies that are needed to address Homeland Security issues.

    DATES:

    The agreement became effective February 23, 2004.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Karen A. Wolnik, Forensic Chemistry Center (HFR-CE502), Food and Drug Administration, 6751 Steger Dr., Cincinnati, OH 45237, 513-679-2700 ext. 181.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

    Start Signature

    Dated: July 21, 2004.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature Start Printed Page 46158

    Start Printed Page 46159

    Start Printed Page 46160

    Start Printed Page 46161

    Start Printed Page 46162

    Start Printed Page 46163

    Start Printed Page 46164

    Start Printed Page 46165 End Supplemental Information

    [FR Doc. 04-17511 Filed 7-30-04; 8:45 am]

    BILLING CODE 4160-01-C

Document Information

Effective Date:
2/23/2004
Published:
08/02/2004
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
04-17511
Dates:
The agreement became effective February 23, 2004.
Pages:
46157-46165 (9 pages)
Docket Numbers:
FDA 225-04-4003
PDF File:
04-17511.pdf